Literature DB >> 32795616

A Preliminary Report of Gonadal-Sparing TBI Using a VMAT Technique.

Erik S Blomain1, Nataliya Kovalchuk1, Beth K Neilsen2, Lawrie Skinner1, Richard T Hoppe1, Susan M Hiniker3.   

Abstract

Reproductive toxicity is common after total body irradiation (TBI) and has major quality of life implications for patients. In that context, this is the first report of gonadal-sparing volumetric-modulated arc therapy (VMAT) TBI, successfully delivered in a boy and a girl with aplastic anemia. Both patients' VMAT TBI plans demonstrated improved gonadal sparing versus simulated conventional 2-dimensional (2D) approach (mean testes dose, 0.45 Gy VMAT vs 0.72 Gy 2D; mean ovary dose, 0.64 Gy VMAT vs 1.47 Gy 2D). Planning target volume coverage was also improved for both cases with the VMAT plan versus conventional 2D plan (2 Gy D90% vs 1.9 Gy D90%, respectively). Given these dosimetric advantages, the present study can serve as a proof-of-concept for further prospective studies evaluating this technique for wider applications in populations receiving TBI.
Copyright © 2020 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32795616     DOI: 10.1016/j.prro.2020.07.006

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN: 1879-8500


  3 in total

1.  Evaluation of volumetric modulated arc therapy (VMAT) - based total body irradiation (TBI) in pediatric patients.

Authors:  Kadir Yaray; Edrine Damulira
Journal:  Rep Pract Oncol Radiother       Date:  2021-08-12

2.  Automatic treatment planning for VMAT-based total body irradiation using Eclipse scripting.

Authors:  Jose R Teruel; Sameer Taneja; Paulina E Galavis; K Sunshine Osterman; Allison McCarthy; Martha Malin; Naamit K Gerber; Christine Hitchen; David L Barbee
Journal:  J Appl Clin Med Phys       Date:  2021-02-10       Impact factor: 2.102

3.  Feasibility study of volumetric modulated arc therapy with Halcyon™ linac for total body irradiation.

Authors:  Takuya Uehara; Hajime Monzen; Mikoto Tamura; Masahiro Inada; Masakazu Otsuka; Hiroshi Doi; Kenji Matsumoto; Yasumasa Nishimura
Journal:  Radiat Oncol       Date:  2021-12-14       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.